Wang-Yu Cai

488 total citations
22 papers, 275 citations indexed

About

Wang-Yu Cai is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Wang-Yu Cai has authored 22 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Reproductive Medicine, 7 papers in Obstetrics and Gynecology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Wang-Yu Cai's work include Ovarian function and disorders (11 papers), Reproductive Biology and Fertility (6 papers) and Pregnancy and preeclampsia studies (4 papers). Wang-Yu Cai is often cited by papers focused on Ovarian function and disorders (11 papers), Reproductive Biology and Fertility (6 papers) and Pregnancy and preeclampsia studies (4 papers). Wang-Yu Cai collaborates with scholars based in China and Hong Kong. Wang-Yu Cai's co-authors include Jian Xu, Xi Luo, Xiaoke Wu, Ying Pan, Bing Li, Xiaoli Liu, Jinhu Dong, Ruili Li, Hongli Ma and Bingbing Wu and has published in prestigious journals such as Journal of Materials Chemistry B, Journal of Medical Virology and Frontiers in Endocrinology.

In The Last Decade

Wang-Yu Cai

20 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wang-Yu Cai China 11 121 80 45 39 37 22 275
Elaheh Ouladsahebmadarek Iran 11 151 1.2× 73 0.9× 43 1.0× 53 1.4× 88 2.4× 46 406
Junjun Li China 9 92 0.8× 45 0.6× 20 0.4× 17 0.4× 56 1.5× 37 314
M. Will United States 7 217 1.8× 113 1.4× 32 0.7× 64 1.6× 56 1.5× 17 329
Mehmet Külhan Türkiye 11 83 0.7× 94 1.2× 48 1.1× 92 2.4× 29 0.8× 43 287
Behnaz Khani Iran 8 211 1.7× 144 1.8× 24 0.5× 26 0.7× 34 0.9× 21 318
Remzi Atılgan Türkiye 12 159 1.3× 86 1.1× 55 1.2× 149 3.8× 33 0.9× 47 397
Liangzhen Xie China 11 106 0.9× 64 0.8× 16 0.4× 15 0.4× 68 1.8× 31 255
Haitham Bahaa Egypt 10 84 0.7× 81 1.0× 44 1.0× 60 1.5× 25 0.7× 15 211
Ümit Naykı Türkiye 11 99 0.8× 77 1.0× 48 1.1× 88 2.3× 38 1.0× 38 310
Weihong Hu China 8 249 2.1× 170 2.1× 35 0.8× 11 0.3× 135 3.6× 16 369

Countries citing papers authored by Wang-Yu Cai

Since Specialization
Citations

This map shows the geographic impact of Wang-Yu Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang-Yu Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang-Yu Cai more than expected).

Fields of papers citing papers by Wang-Yu Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wang-Yu Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang-Yu Cai. The network helps show where Wang-Yu Cai may publish in the future.

Co-authorship network of co-authors of Wang-Yu Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Wang-Yu Cai. A scholar is included among the top collaborators of Wang-Yu Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wang-Yu Cai. Wang-Yu Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Wang-Yu & Xi Luo. (2024). Investigation of Fructus Ligustri Lucidi for Premature Ovarian Insufficiency based on a Network Pharmacology and Experiment Verifications. Combinatorial Chemistry & High Throughput Screening. 28(13). 2287–2301.
2.
Xia, Qing, et al.. (2024). The discriminatory capability of anthropometric measures in predicting reproductive outcomes in Chinese women with PCOS. Journal of Ovarian Research. 17(1). 186–186. 1 indexed citations
4.
Cai, Wang-Yu, Xi Luo, Wei Wu, et al.. (2022). Metabolic differences in women with premature ovarian insufficiency: a systematic review and meta-analysis. Journal of Ovarian Research. 15(1). 109–109. 24 indexed citations
5.
Cai, Wang-Yu, Xi Luo, Hongli Ma, Xiaoguang Shao, & Xiaoke Wu. (2022). Association between preconception serum lipid concentrations and treatment outcomes in women with PCOS who underwent ovulation induction. Reproductive BioMedicine Online. 45(4). 805–814. 9 indexed citations
6.
Cai, Wang-Yu, et al.. (2022). Insulin resistance in women with recurrent miscarriage: a systematic review and meta-analysis. BMC Pregnancy and Childbirth. 22(1). 916–916. 17 indexed citations
8.
Wu, Bingbing, et al.. (2021). Hydrogel, a novel therapeutic and delivery strategy, in the treatment of intrauterine adhesions. Journal of Materials Chemistry B. 9(33). 6536–6552. 27 indexed citations
9.
Luo, Xi, Wang-Yu Cai, Hongli Ma, et al.. (2021). Associations of Serum Magnesium With Insulin Resistance and Testosterone in Women With Polycystic Ovary Syndrome. Frontiers in Endocrinology. 12. 683040–683040. 11 indexed citations
10.
Wu, Wei, et al.. (2021). MiR-let-7d-3p inhibits granulosa cell proliferation by targeting TLR4 in polycystic ovary syndrome. Reproductive Toxicology. 106. 61–68. 10 indexed citations
11.
Luo, Xi, Wang-Yu Cai, & Xiaoke Wu. (2021). Prevalence, Pattern and Predictors for Dyslipidemia of Chinese Women With Polycystic Ovary Syndrome. Frontiers in Cardiovascular Medicine. 8. 790454–790454. 13 indexed citations
12.
Luo, Xi, et al.. (2021). Predictive Value of Circulating Sex Hormone-Binding Globulin for Gestational Diabetes: A Meta-Analysis. Biomarkers in Medicine. 15(12). 1043–1053. 1 indexed citations
13.
Li, Yanrui, et al.. (2021). Identification of a MicroRNA Signature Associated With Lymph Node Metastasis in Endometrial Endometrioid Cancer. Frontiers in Genetics. 12. 650102–650102. 8 indexed citations
14.
Cai, Wang-Yu, et al.. (2021). Serum Lipid Levels and Treatment Outcomes in Women Undergoing Assisted Reproduction: A Retrospective Cohort Study. Frontiers in Endocrinology. 12. 633766–633766. 21 indexed citations
15.
Cai, Wang-Yu, et al.. (2021). Predictive value of the number of frozen blastocysts in live birth rates of the transferred fresh embryos. Journal of Ovarian Research. 14(1). 83–83. 7 indexed citations
16.
Cai, Wang-Yu, et al.. (2020). <p>Comparison of GnRH-a Prolonged Protocol and Short GnRH-a Long Protocol in Patients with Thin Endometrium for Assisted Reproduction: A Retrospective Cohort Study</p>. Drug Design Development and Therapy. Volume 14. 3673–3682. 14 indexed citations
17.
Cai, Wang-Yu, et al.. (2020). Clinical characteristics, cause analysis and infectivity of COVID‐19 nucleic acid repositive patients: A literature review. Journal of Medical Virology. 93(3). 1288–1295. 19 indexed citations
19.
Liu, Xiaoli, Jinhu Dong, Wang-Yu Cai, et al.. (2017). The Effect of Thymoquinone on Apoptosis of SK-OV-3 Ovarian Cancer Cell by Regulation of Bcl-2 and Bax. International Journal of Gynecological Cancer. 27(8). 1596–1601. 49 indexed citations
20.
Gong, Rongpeng, et al.. (2010). α-KETOGLUTARIC ACID-MODIFIED CHITOSAN RESIN AS SORBENT FOR ENHANCING METHYLENE BLUE REMOVAL FROM AQUEOUS SOLUTIONS. International Journal of Environmental Research. 4(1). 27–32. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026